TLDR A girl developed vitiligo and psoriasis after hepatitis B treatment, and stopping the treatment didn't help.
The document reported a case of a 10-year-old girl with chronic hepatitis B who developed both vitiligo and psoriasis after being treated with interferon alfa-2a. These skin conditions did not improve even after the interferon treatment was stopped. This was notable because the simultaneous occurrence of vitiligo and psoriasis as a side effect of interferon alfa-2a had not been previously documented. The study highlighted the potent immunomodulatory effects of interferon alfa-2a, which can trigger autoimmune diseases in susceptible individuals.
105 citations
,
September 1995 in “Journal of The American Academy of Dermatology” Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.
41 citations
,
August 2007 in “European Journal of Gastroenterology & Hepatology” A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.
March 2014 in “Journal of The American Academy of Dermatology” The document lists various dermatology topics, treatments, and diagnostic methods.
3 citations
,
March 2014 in “Annals of Hepatology” A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.
64 citations
,
January 2009 in “Canadian Journal of Gastroenterology” Interferon and ribavirin can cause serious skin reactions and other health issues.
34 citations
,
April 2008 in “Journal of the European Academy of Dermatology and Venereology” Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.